Jeito
  • About
  • The team
  • Our portfolio
  • ESG & Impact
  • Newsroom
  • Contact
  • English
    • Français
    • English
Select Page

Rafaèle Tordjman launches JEITO CAPITAL, a new private equity company dedicated to biotech-biopharmaceuticals

by Jeito Life | 13 Jan Mon | English

Paris, January 13, 2020 – Rafaèle Tordjman launches JEITO CAPITAL, a new French and independent investment investor dedicated to biotech and biopharma. The launch is completed by the closing of JEITO I fund’s with the support and investment of renowned...
Next Entries »

Recent Posts

  • Jeito Capital co-leads the oversubscribed €78 million financing in Augustine Therapeutics to develop novel therapies for neuromuscular, cardio-metabolic and neurodegenerative diseases
  • Jeito Capital announces significant participation in $187 million Series A financing for Callio Therapeutics to advance innovative multi-payload ADC programs designed to maximize therapeutic benefit for cancer patients
  • Jeito Capital leads $67.5 million (€64.4 million) Series B financing in XyloCor Therapeutics to develop Novel Gene Therapy in Cardiovascular Disease
  • Jeito Capital announces significant participation in upsized $207.5 million Series C financing in Aviceda Therapeutics to advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials
  • Dr Rafaèle Tordjman Receives L’Agefi’s Prestigious 2024 ‘AM Leader’ Award

Recent Comments

    Mentions et autres liens
    We use cookies on our website to provide you with the most relevant experience by remembering your preferences and repeat visits.
    By clicking on "Accept All", you consent to the use of ALL cookies. However, you can visit "Cookie Settings" to provide controlled consent.
    Cookie settingsAccept all
    Manage consent

    Privacy Overview

    This website uses cookies to enhance your experience when browsing the site. Of these, cookies that are categorized as necessary are stored on your browser because they are essential for the basic functionality of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will only be stored in your browser with your consent. You also have the ability to decline these cookies. But disabling some of these cookies may affect your browsing experience.
    SAVE & ACCEPT